Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial

American Heart Journal

Volumn 165, Issue 2, 2013, Pages 216-225

  Ambrosy, Andrew P ^a   Vaduganathan, Muthiah ^b   Mentz, Robert J ^c   Greene, Stephen J ^d   Subačius, Haris ^d   Konstam, Marvin A ^e   Maggioni, Aldo P ^f   Swedberg, Karl ^g   Gheorghiade, Mihai ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f ANMCO RESEARCH CENTER   (Italy)

^g UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; INOTROPIC AGENT; NATRIURETIC FACTOR; SODIUM; UREA;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; DYSPNEA; EDEMA; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; GENDER; GEOGRAPHY; HEART ATRIUM ARRHYTHMIA; HEART EJECTION FRACTION; HEART FAILURE; HEART MURMUR; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; RACE; REVASCULARIZATION; RISK ASSESSMENT; SODIUM BLOOD LEVEL; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL;

AGED; BENZAZEPINES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART FAILURE; HUMANS; INPATIENTS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, VASOPRESSIN; STROKE VOLUME; SURVIVAL RATE; SYSTOLE; TREATMENT OUTCOME; UNITED STATES;

EID: 84872834070     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.11.004     Document Type: Article

References (21)

1. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 1 2012 188 197
2. V.L. Roger, A.S. Go, and D.M. Lloyd-Jones Heart disease and stroke statistics - 2012 update: a report from the American Heart Association Circulation 125 1 2012 e2 e220
3. M. Gheorghiade, M. Vaduganathan, and A. Ambrosy Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure Heart Fail Rev 2012
4. M.E. Harinstein, J.D. Flaherty, and G.C. Fonarow Clinical assessment of acute heart failure syndromes: emergency department through the early post-discharge period Heart 97 19 2011 1607 1618
5. M. Gheorghiade, W.T. Abraham, and N.M. Albert Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 18 2006 2217 2226
6. K.F. Adams Jr., G.C. Fonarow, and C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2 2005 209 216
7. R.S. Bhatia, J.V. Tu, and D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 3 2006 260 269
8. M. Gheorghiade, C. Orlandi, and J.C. Burnett Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) J Card Fail 11 4 2005 260 269
9. M. Gheorghiade, M.A. Konstam, and J.C. Burnett Jr. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials JAMA 297 12 2007 1332 1343
10. M.A. Konstam, M. Gheorghiade, and J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial JAMA 297 12 2007 1319 1331
11. N.C. Wang, A.P. Maggioni, and M.A. Konstam Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction JAMA 299 22 2008 2656 2666
12. S.A. Hunt, W.T. Abraham, and M.H. Chin 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation Circulation 119 14 2009 e391 e479
13. N.C. Wang, G.C. Fonarow, and M. Gheorghiade The potential application of electrophysiology diagnostics and therapeutics in acute heart failure syndromes Heart Fail Rev 16 5 2011 437 439
14. N.C. Wang, S. Bhattacharya, and M. Gheorghiade The potential role of cardiac resynchronization therapy in acute heart failure syndromes Heart Fail Rev 16 5 2011 481 490
15. N.C. Wang, J.P. Piccini, and M. Gheorghiade Implantable cardioverter-defibrillator implementation in acute heart failure syndromes: unanswered questions Heart Fail Rev 16 5 2011 477 480
16. W.T. Abraham, K.F. Adams, and G.C. Fonarow In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE) J Am Coll Cardiol 46 1 2005 57 64
17. M. Gheorghiade, and E. Braunwald Hospitalizations for heart failure in the United States - a sign of hope JAMA 306 15 2011 1705 1706
18. J. Chen, S.L. Normand, and Y. Wang National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 15 2011 1669 1678
19. G.C. Fonarow, K.F. Adams Jr., and W.T. Abraham Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis JAMA 293 5 2005 572 580
20. D.S. Lee, P.C. Austin, and J.L. Rouleau Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 19 2003 2581 2587
21. C.M. O'Connor, A.B. Miller, and J.E. Blair Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program Am Heart J 159 5 2010 841 e1 849 e1